Cancer Outcomes 2013 - University of Colorado Hospital
-
Upload
university-of-colorado-health -
Category
Documents
-
view
213 -
download
0
description
Transcript of Cancer Outcomes 2013 - University of Colorado Hospital
C a n C e r O u t C O m e s | 2 0 1 3
4-10 // Outcomes Data
12 // Colorado’s Only Federally Designated Cancer Center
4 // Brain & CNS (Malignant Only) 5–Year Survival
4 // Breast Cancer 5–Year Survival
5 // Colon Cancer 5–Year Survival
5 // Corpus Uteri 5 –Year Survival
6 // Liver Cancer 5–Year Survival
6 // Lung Cancer 5 –Year Survival
7 // Lymphoma Cancer 5–Year Survival
7 // Melanoma of the Skin 5–Year Survival
8 // Ovarian Cancer 5–Year Survival
8 // Pancreas Cancer 5 –Year Survival
9 // Prostate Cancer 5–Year Survival
ta bl e Of COn t e n t s
university Of COlOradO HOspital is tHe leading aCademiC mediCal Center in tHe natiOn.
University of Colorado Hospital (UCH) is recognized as the highest-performing academic hospital in the United
States for delivering quality health care by the University HealthSystem Consortium for two years in a row, and is
ranked as the best hospital in the Denver metro area and one of the best in the country by U.S. News & World Report.
UCH is best known as an innovator in patient care and often is one of the first hospitals to bring new medicine to the
patient’s bedside. The hospital’s physicians are affiliated with the University of Colorado School of Medicine, part of
the University of Colorado system. Based at the expansive Anschutz Medical Campus in Aurora, Colo., UCH is where
patient care, research and education converge to establish the future of health care delivery.
3
*n=18
56%
36%
18%
7%
46%
31%
11%
3%
45%
26%
11%
2%
Stage I Stage II Stage III Stage IV
Lung Cancer - 5 Year Survival
UCH State National
22%
13%
0%
3%
20%
10%
4% 2%
20%
10%
3% 2%
Stage I* Stage II Stage III Stage IV
Pancreas Cancer - 5 Year Survival
UCH State National
73%
61% 54%
49% 47%
58%
45% 38% 36% 34%
52%
36% 30%
37%
25%
Year 1 Year 2 Year 3 Year 4 Year 5
Brain & CNS (Malignant Only) - Survival by Year
UCH State National
83% 77% 79% 77%
Lymphoma - 5 Year Survival
UCH State National
b r a i n & C n s ( m a l i g n a n t O n l y ) 5 – y e a r s u r v i v a l
UCH
Colorado
National
K e y
O b s e r v e d s u r v i v a l d a t a 2 0 0 3 - 2 0 0 6
( a J C C 6 t H e d i t i O n )
93% 94% 95%
45%
84% 89% 92%
36%
83% 91% 91%
38%
Stage I Stage II Stage III Stage IV
Prostate Cancer - 5 Year Survival
UCH State National
93%
69%
58%
11%
90%
68% 60%
10%
91%
66%
54%
13%
Stage I Stage II Stage III Stage IV
Melanoma of the Skin - 5 Year Survival
UCH State National
96% 92%
62%
41%
92% 86%
75%
26%
92% 85%
67%
21%
Stage I Stage II Stage III Stage IV
Breast Cancer - 5 Year Survival
UCH State National
Lung Cancer - 5 Year Survival
b r e a s t C a n C e r 5 – y e a r s u r v i v a l
4
Ou t C Ome s d ata
*n = 14
*n = 22
38%
20%
68%
37%
17%
66%
33%
15%
Stage I Stage II* Stage III Stage IV
88%
69%
49%
23%
74% 67% 64%
9%
78% 67%
55%
10%
Stage I Stage II Stage III* Stage IV
Colon Cancer - 5 Year Survival
UCH State National
C O l O n C a n C e r 5 – y e a r s u r v i v a l
*N = 22
*n= 18
*n = 20
83% 73% 77%
53%
79% 77% 70%
52%
74% 73%
61% 50%
Stage I Stage II Stage III* Stage IV
UCH State National
52% 48%
14% 14%
35%
25%
4% 2%
33%
26%
6% 2%
Stage I Stage II Stage III Stage IV
Liver Cancer - 5 Year Survival
UCH State National
88% 82%
74%
25%
89%
76% 67%
17%
88%
73%
53%
16%
Stage I Stage II Stage III Stage IV*
Corpus Uteri - 5 Year Survival
UCH State National
94% 84% 89%
68%
85%
66%
Ovarian Cancer - 5 Year Survival
UCH State National
C O r p u s u t e r i 5 – y e a r s u r v i v a l
*N = 20
5
*n=18
56%
36%
18%
7%
46%
31%
11%
3%
45%
26%
11%
2%
Stage I Stage II Stage III Stage IV
Lung Cancer - 5 Year Survival
UCH State National
22%
13%
0%
3%
20%
10%
4% 2%
20%
10%
3% 2%
Stage I* Stage II Stage III Stage IV
Pancreas Cancer - 5 Year Survival
UCH State National
73%
61% 54%
49% 47%
58%
45% 38% 36% 34%
52%
36% 30%
37%
25%
Year 1 Year 2 Year 3 Year 4 Year 5
Brain & CNS (Malignant Only) - Survival by Year
UCH State National
83% 77% 79% 77%
Lymphoma - 5 Year Survival
UCH State National
56%
l u n g C a n C e r 5 – y e a r s u r v i v a l
*n= 18
*n = 20
83% 73% 77%
53%
79% 77% 70%
52%
74% 73%
61% 50%
Stage I Stage II Stage III* Stage IV
UCH State National
52% 48%
14% 14%
35%
25%
4% 2%
33%
26%
6% 2%
Stage I Stage II Stage III Stage IV
Liver Cancer - 5 Year Survival
UCH State National
88% 82%
74%
25%
89%
76% 67%
17%
88%
73%
53%
16%
Stage I Stage II Stage III Stage IV*
Corpus Uteri - 5 Year Survival
UCH State National
94% 84% 89%
68%
85%
66%
Ovarian Cancer - 5 Year Survival
UCH State National
l i v e r C a n C e r 5 – y e a r s u r v i v a l
UCH
Colorado
National
K e y
O b s e r v e d s u r v i v a l d a t a 2 0 0 3 - 2 0 0 6
( a J C C 6 t H e d i t i O n )
6
OU T C OME S d aTa
93% 94% 95%
45%
84% 89% 92%
36%
83% 91% 91%
38%
Stage I Stage II Stage III Stage IV
Prostate Cancer - 5 Year Survival
UCH State National
93%
69%
58%
11%
90%
68% 60%
10%
91%
66%
54%
13%
Stage I Stage II Stage III Stage IV
Melanoma of the Skin - 5 Year Survival
UCH State National
96% 92%
62%
41%
92% 86%
75%
26%
92% 85%
67%
21%
Stage I Stage II Stage III Stage IV
Breast Cancer - 5 Year Survival
UCH State National
Lung Cancer - 5 Year Survival
m e l a n O m a O f t H e s K i n 5 – y e a r s u r v i v a l
*n= 18
*n = 20
83% 73% 77%
53%
79% 77% 70%
52%
74% 73%
61% 50%
Stage I Stage II Stage III* Stage IV
UCH State National
52% 48%
14% 14%
35%
25%
4% 2%
33%
26%
6% 2%
Stage I Stage II Stage III Stage IV
Liver Cancer - 5 Year Survival
UCH State National
88% 82%
74%
25%
89%
76% 67%
17%
88%
73%
53%
16%
Stage I Stage II Stage III Stage IV*
Corpus Uteri - 5 Year Survival
UCH State National
94% 84% 89%
68%
85%
66%
Ovarian Cancer - 5 Year Survival
UCH State National
83% 79%
l y m p H O m a 5– y e a r s u r v i v a l
*N = 18
7
*n=18
56%
36%
18%
7%
46%
31%
11%
3%
45%
26%
11%
2%
Stage I Stage II Stage III Stage IV
Lung Cancer - 5 Year Survival
UCH State National
22%
13%
0%
3%
20%
10%
4% 2%
20%
10%
3% 2%
Stage I* Stage II Stage III Stage IV
Pancreas Cancer - 5 Year Survival
UCH State National
73%
61% 54%
49% 47%
58%
45% 38% 36% 34%
52%
36% 30%
37%
25%
Year 1 Year 2 Year 3 Year 4 Year 5
Brain & CNS (Malignant Only) - Survival by Year
UCH State National
83% 77% 79% 77%
Lymphoma - 5 Year Survival
UCH State National
p a n C r e a s C a n C e r 5 – y e a r s u r v i v a l
*N = 18
94% 84%
38%
20%
89%
68%
37%
17%
85%
66%
33%
15%
Stage I Stage II* Stage III Stage IV
Ovarian Cancer - 5 Year Survival
UCH State National
O v a r i a n 5– y e a r s u r v i v a l
*N = 14
UCH
Colorado
National
K e y
O b s e r v e d s u r v i v a l d a t a 2 0 0 3 - 2 0 0 6
( a J C C 6 t H e d i t i O n )
8
OU T C OME S d aTa
93% 94% 95%
45%
84% 89% 92%
36%
83% 91% 91%
38%
Stage I Stage II Stage III Stage IV
Prostate Cancer - 5 Year Survival
UCH State National
93%
69%
58%
11%
90%
68% 60%
10%
91%
66%
54%
13%
Stage I Stage II Stage III Stage IV
Melanoma of the Skin - 5 Year Survival
UCH State National
96% 92%
62%
41%
92% 86%
75%
26%
92% 85%
67%
21%
Stage I Stage II Stage III Stage IV
Breast Cancer - 5 Year Survival
UCH State National
Lung Cancer - 5 Year Survival
p r O s t a t e C a n C e r 5 – y e a r s u r v i v a l
*N = 16
9
NCI CANCER CENTERS IN THE USA
= NCI Cancer Center
= NCI Comprehensive Cancer Center
= UCH, NCI Comprehensive Cancer Center
10
The University of Colorado Cancer Center is the hub of cancer research in Colorado. We are a consortium of more
than 400 researchers and physicians at three state universities and six institutions, all working toward one goal:
translating science into cancer survivorship.
C O l O r a d O ’ s O n l y f e d e r a l l y d e s i g n a t e d C a n C e r C e n t e r t a C K l e s C a n C e r f r O m a l l a n g l e s
11
Through collaboration and innovation, CU Cancer Center
members discover, develop and deliver breakthroughs that improve
cancer care for people and companion animals. We focus on:
Personalized care that embraces the best clinical practices of
prevention, diagnosis, treatment and survivorship.
• Innovative interdisciplinary research.
• Premier clinical and scientific training.
• Creative partnerships.
Founded in 1988, CU Cancer Center is the only comprehensive
cancer center designated by the National Cancer Institute in
Colorado and the Rocky Mountain region. Our founding director,
Paul A. Bunn, Jr., MD, led the organization until 2009. In 2010, Dan
Theodorescu, MD, PhD, ushered CU Cancer Center into a new era.
CU Cancer Center is headquartered on the Anschutz Medical
Campus in Aurora, Colo., in the University of Colorado School of
Medicine. Affiliated institutions include University of Colorado
Denver, University of Colorado Boulder, Colorado State University
(including its Flint animal cancer center), University of Colorado
Health, Children’s Hospital Colorado, Denver Veterans Affairs
Medical Center, Denver Health, National Jewish Health and
the Kaiser Permanente’s Institute of Health Research. Our
clinical outreach program extends throughout Colorado and
neighboring states.
HigHl igH t s a nd a C C Omp l i s Hme n t sCU Cancer Center is known clinically for its personalized cancer
treatments and robust and diverse clinical research and trials
program and. Our scientific expertise ranges from understanding
how chromosome structure controls cancer cell behavior, to
understanding how the immune system impacts cancer to carrying
out Phase I trials that bring new therapies to market. Other
strengths include:
NCCN member. The CU Cancer Center is a member of the National
Comprehensive Cancer Network, an alliance of 23 of the world’s
leading cancer centers dedicated to improving the quality,
effectiveness and efficiency of care provided to patients with cancer.
Lung cancer care and research. CU Cancer Center is one of the
world’s best lung cancer research and treatment programs.
We are the coordinating center for the Lung Cancer Mutations
Consortium, funded by a $5.3 million American Reinvestment and
Recovery Act Grand Opportunities grant.
Cancer survivorship. We’re one of eight LIVESTRONG Cancer
Survivorship Centers of Excellence and home to the region’s
three full-scale cancer survivorship clinics: The HOPE clinic for
young adult survivors of cancer at Children’s Hospital Colorado,
the TACTIC clinic for adult survivors of childhood cancer at
University of Colorado Hospital, and the THRIVE clinic for
transitioning adult cancer patients back to primary care.
Cancer screening. The Colorado Colorectal Screening Program
is a national model for ensuring uninsured Coloradans who meet
certain financial and risk criteria receive colon cancer screening
and follow-up care at no cost to them.
Molecular tumor testing. CU Cancer Center has developed tests
that find specific gene defects that can be targeted with new drugs.
These tests have positioned CU Cancer Center as a national leader
for clinical trials of “targeted” drugs.
Cancer clinical trials. CU Cancer Center’s Phase I Trials program
is the only program of its kind in the region and nationally
recognized. In addition, with the largest number of human cancer
clinicals in the region, CU Cancer Center provides patients across
the state and region with access to cutting-edge cancer care.
Structural biology. CU Cancer Center’s NMR spectroscopy and
X-ray facilities are among the best in the world and have helped
recruit world-class scientists to use them. The machines, housed
in CU Cancer Center’s Structural Biology shared resource, help
scientists solve structures of cancer molecules to develop drugs
with precise molecular targeting.
Animal cancer treatment. The Colorado State University Flint
Animal Cancer Center is the world leader in research and
treatment of spontaneously occurring cancers in companion
animals, especially dogs. CU Cancer Center’s members at CSU
collaborate with researchers in human cancers, and clinical trials
in dogs have led to new treatments for people.
l e a r n mOr e :www.coloradocancercenter.org
www.uch.edu
coloradocancerblogs.org
facebook.com/coloradocancercenter